Medicamen Biotech Ltd.

Financial

	Medicamen Biotech	Medico Remedies	Brooks Laboratories
Operational Metrics
Financials
5 yr Average ROE	6.92 %	13.93 %	-23.88 %
5yr average Equity Multiplier	1.44	2.07	1.78
5yr Average Asset Turnover Ratio	0.55	1.49	0.6
5yr Avg Net Profit Margin	8.69 %	4.73 %	-23.79 %
Price to Book	1.92	6.42	3.95
P/E	43.02	38.86	0.0
5yr Avg Cash Conversion Cycle	49.75 Days	53.33 Days	-10.34 Days
Inventory Days	84.58 Days	48.95 Days	93.5 Days
Days Receivable	139.4 Days	129.15 Days	66.75 Days
Days Payable	264.75 Days	124.28 Days	179.8 Days
5yr Average Interest Coverage Ratio	7.03	11.55	-11.84
5yr Avg ROCE	10.34 %	20.03 %	-15.03 %
5yr Avg Operating Profit Margin	15.51 %	7.11 %	-13.23 %
5 yr average Debt to Equity	0.15	0.26	0.21
5yr CAGR Net Profit	-11.57 %	31.26 %	0.22 %
5yr Average Return on Assets	4.73 %	6.88 %	-14.62 %
Shareholdings
Promoter Holding	40.46 %	62.59 %	52.62 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.14 %	-10.75 %	-13.79 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	9.9 %

Business

	Medicamen Biotech	Medico Remedies	Brooks Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals Formulations 100.0 Traded Goods 0 Manufactured Goods 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Traded Goods 1.96 Pharmaceuticals Formulations 0 Manufactured Goods 96.53 Others 1.51	Product Wise Break-Up Pharmaceutical 100.0 Traded Goods 0 Pharmaceuticals Formulations 0 Manufactured Goods 0
Location Wise Break-Up	Location Wise Break-Up India 20.0 Outside India 0 Others 80.0	Location Wise Break-Up India 14.26 Outside India 85.74	-